Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Downgrades Epizyme to Underweight, Lowers Price Target to $5

Morgan Stanley analyst David Lebowitz downgrades Epizyme (NASDAQ:EPZM) from Equal-Weight to Underweight and lowers the price target from $10 to $5.

byBenzinga Newsdesk

August 10, 2021

1 minute read

Morgan Stanley analyst David Lebowitz downgrades Epizyme (NASDAQ:EPZM) from Equal-Weight to Underweight and lowers the price target from $10 to $5.

Morgan Stanley Maintains Equal-Weight on Booking Holdings, Raises Price Target to $2820

By Benzinga Newsdesk

Today, 6:26 AM

Morgan Stanley maintains Booking Holdings (NASDAQ:BKNG) with a Equal-Weight and raises the price target from $2660 to $2820.

BKNG

Alibaba, Nio Stocks Surge: Hang Seng Rises Over 3% As Tech, EV Rally Outweighs COVID-19 Worries

By Bhavik Nair

Today, 6:26 AM

Hong Kong shares traded in the green on Friday with the benchmark Hang Seng opening 3.36% higher. Investors and traders seem to have shrugged off a rise in COVID-19 cases in China which hit their highest since August.

BABA

Apple Supplier Foxconn Expects Flat Q4 Amid iPhone Factory Shutdown: What Does It Mean For Cupertino?

By Shanthi Rexaline

Today, 6:26 AM

Apple Inc.

AAPL

JP Morgan Downgrades ON24 to Neutral, Lowers Price Target to $32

By Benzinga Newsdesk

Today, 6:26 AM

JP Morgan analyst Sterling Auty downgrades ON24 (NYSE:ONTF) from Overweight to Neutral and lowers the price target from $85 to $32.

ONTF

Morgan Stanley Downgrades Epizyme to Underweight, Lowers Price Target to $5

Related Posts

Morgan Stanley Maintains Equal-Weight on Booking Holdings, Raises Price Target to $2820

Alibaba, Nio Stocks Surge: Hang Seng Rises Over 3% As Tech, EV Rally Outweighs COVID-19 Worries

Apple Supplier Foxconn Expects Flat Q4 Amid iPhone Factory Shutdown: What Does It Mean For Cupertino?

JP Morgan Downgrades ON24 to Neutral, Lowers Price Target to $32